The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway

被引:118
作者
Bravo-San Pedro, Jose M. [1 ]
Niso-Santano, Mireia [1 ]
Gomez-Sanchez, Ruben [1 ]
Pizarro-Estrella, Elisa [1 ]
Aiastui-Pujana, Ana [2 ,3 ]
Gorostidi, Ana [2 ,3 ]
Climent, Vicente [4 ]
Lopez de Maturana, Rakel [5 ]
Sanchez-Pernaute, Rosario [5 ]
Lopez de Munain, Adolfo [6 ]
Fuentes, Jose M. [1 ]
Gonzalez-Polo, Rosa A. [1 ]
机构
[1] Univ Extremadura, Dept Bioquim Biol & Mol Genet & E Enfermeria & TO, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Avda Univ S-N, Caceres 10003, Spain
[2] Inst Biodonostia, Neurosci Area, San Sebastian 20014, Spain
[3] CIBERNED, San Sebastian 20014, Spain
[4] Univ Extremadura, Dept Anat & Embriol Humana, Fac Med, Badajoz 06071, Spain
[5] Fdn Inbiomed, Lab Celulas Madre & Neurorreparac, San Sebastian 20009, Spain
[6] Hosp Donostia, Serv Neurol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Inst Biodonostia, San Sebastian 20014, Spain
关键词
Autophagy; LRRK2; G2019S; ERK; Parkinson's disease; REPEAT KINASE 2; NEUROBLASTOMA SH-SY5Y CELLS; ALPHA-SYNUCLEIN AGGREGATION; PARAQUAT-INDUCED AUTOPHAGY; PARKINSONS-DISEASE; REGULATES AUTOPHAGY; HT-29; CELLS; DEATH; PROTEINS; STRESS;
D O I
10.1007/s00018-012-1061-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in leucine-rich repeat kinase 2 (LRRK2) are a major cause of familial Parkinsonism, and the G2019S mutation of LRRK2 is one of the most prevalent mutations. The deregulation of autophagic processes in nerve cells is thought to be a possible cause of Parkinson's disease (PD). In this study, we observed that G2019S mutant fibroblasts exhibited higher autophagic activity levels than control fibroblasts. Elevated levels of autophagic activity can trigger cell death, and in our study, G2019S mutant cells exhibited increased apoptosis hallmarks compared to control cells. LRRK2 is able to induce the phosphorylation of MAPK/ERK kinases (MEK). The use of 1-4 -diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), a highly selective inhibitor of MEK1/2, reduced the enhanced autophagy and sensibility observed in G2019S LRRK2 mutation cells. These data suggest that the G2019S mutation induces autophagy via MEK/ERK pathway and that the inhibition of this exacerbated autophagy reduces the sensitivity observed in G2019S mutant cells.
引用
收藏
页码:121 / 136
页数:16
相关论文
共 50 条
[21]   G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia [J].
Pchelina, Sofya N. ;
Yakimovskii, Andrei F. ;
Ivanova, Olga N. ;
Emelianov, Anton K. ;
Zakharchuk, Andrei H. ;
Schwarzman, Alexander L. .
MOVEMENT DISORDERS, 2006, 21 (12) :2234-2236
[22]   Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice [J].
Winner, B. ;
Melrose, H. L. ;
Zhao, C. ;
Hinkle, K. M. ;
Yue, M. ;
Kent, C. ;
Braithwaite, A. T. ;
Ogholikhan, S. ;
Aigner, R. ;
Winkler, J. ;
Farrer, M. J. ;
Gage, F. H. .
NEUROBIOLOGY OF DISEASE, 2011, 41 (03) :706-716
[23]   G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice [J].
Novello, Salvatore ;
Arcuri, Ludovico ;
Dovero, Sandra ;
Dutheil, Nathalie ;
Shimshek, Derya R. ;
Bezard, Erwan ;
Morari, Michele .
NEUROBIOLOGY OF DISEASE, 2018, 120 :21-33
[24]   Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers [J].
Vilas, Dolores ;
Ispierto, Lourdes ;
Alvarez, Ramiro ;
Pont-Sunyer, Claustre ;
Jose Marti, Maria ;
Valldeoriola, Francesc ;
Compta, Yaroslau ;
de Fabregues, Oriol ;
Hernandez-Vara, Jorge ;
Puente, Victor ;
Calopa, Matilde ;
Jauma, Serge ;
Campdelacreu, Jaume ;
Aguilar, Miquel ;
Quilez, Pilar ;
Casquero, Pilar ;
Lomena, Francisco ;
Rios, Jose ;
Tolosa, Eduardo .
PARKINSONISM & RELATED DISORDERS, 2015, 21 (10) :1170-1176
[25]   G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy [J].
Yakhine-Diop, Sokhna M. S. ;
Bravo-San Pedro, Jose M. ;
Gomez-Sanchez, Ruben ;
Pizarro-Estrella, Elisa ;
Rodriguez-Arribas, Mario ;
Climent, Vicente ;
Aiastui, Ana ;
Lopez de Munain, Adolfo ;
Fuentes, Jose M. ;
Gonzalez-Polo, Rosa A. .
TOXICOLOGY, 2014, 324 :1-9
[26]   The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation [J].
Hassin-Baer, Sharon ;
Laitman, Yael ;
Azizi, Esther ;
Molchadski, Irena ;
Galore-Haskel, Gilli ;
Barak, Frida ;
Cohen, Oren S. ;
Friedman, Eitan .
JOURNAL OF NEUROLOGY, 2009, 256 (03) :483-487
[27]   ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression [J].
Zhu, Yuangang ;
Wang, Chunyan ;
Yu, Mei ;
Cui, Jie ;
Liu, Liang ;
Xu, Zhiheng .
PROTEIN & CELL, 2013, 4 (09) :711-721
[28]   Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of α-synuclein [J].
Ho, Dong Hwan ;
Seol, Wongi ;
Son, Ilhong .
CELL CYCLE, 2019, 18 (04) :467-475
[29]   Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation [J].
Su, Yu-Chin ;
Qi, Xin .
HUMAN MOLECULAR GENETICS, 2013, 22 (22) :4545-4561
[30]   Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers [J].
Schootemeijer, S. ;
Coker, D. ;
Shelton, J. F. ;
Chanoff, E. ;
Rowbotham, H. M. ;
Darweesh, S. K. L. ;
Bloem, B. R. ;
Cannon, P. ;
de Vries, N. M. .
PARKINSONISM & RELATED DISORDERS, 2023, 113